Aarti Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LRU01027
  • NSEID: AARTIPHARM
  • BSEID: 543748
INR
721.55
-1.45 (-0.2%)
BSENSE

Dec 05

BSE+NSE Vol: 1.51 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
418.33
386.19
563.78
537.78
458.03
555.49
505.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
418.33
386.19
563.78
537.78
458.03
555.49
505.77
Raw Material Cost
203.46
191.42
185.45
261.19
213.97
208.18
201.52
Purchase of Finished goods
23.26
21.82
-16.27
7.87
98.10
86.94
59.91
(Increase) / Decrease In Stocks
-16.95
-43.84
109.57
6.25
-83.10
31.50
-8.31
Employee Cost
43.41
41.26
43.37
41.63
37.73
39.23
37.40
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.00
0.00
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
90.43
80.28
96.03
92.23
97.66
93.19
97.74
Total Expenditure (Excl Depreciation)
343.62
290.95
418.15
409.17
364.36
459.03
388.26
Operating Profit (PBDIT) excl Other Income
74.71
95.24
145.63
128.61
93.67
96.46
117.51
Other Income
0.05
1.60
-1.61
5.03
4.48
2.22
2.03
Operating Profit (PBDIT)
74.76
96.84
144.02
133.64
98.15
98.68
119.54
Interest
10.67
6.79
6.58
9.97
5.51
4.83
4.68
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
64.09
90.05
137.44
123.67
92.64
93.85
114.86
Depreciation
24.77
22.79
22.82
23.04
20.88
20.17
19.12
Profit Before Tax
38.69
65.45
114.62
100.63
71.77
73.68
95.75
Tax
10.77
15.95
26.28
26.64
17.15
18.22
30.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.56
51.30
88.34
73.99
54.62
55.45
65.25
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.56
51.30
88.34
73.99
54.62
55.45
65.25
Share in Profit of Associates
-0.64
-1.80
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.92
49.50
88.34
73.99
54.62
55.45
65.25
Equity Capital
45.32
45.32
45.32
45.31
45.31
45.31
45.31
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.08
5.46
9.75
8.16
6.03
6.12
7.2
Diluted Earnings per share
3.08
5.46
9.74
8.16
6.02
6.12
7.2
Operating Profit Margin (Excl OI)
17.86%
24.66%
25.83%
23.91%
20.45%
17.36%
23.23%
Gross Profit Margin
15.32%
23.32%
24.38%
23.0%
20.23%
16.89%
22.71%
PAT Margin
6.67%
12.82%
15.67%
13.76%
11.92%
9.98%
12.9%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 8.32% vs -31.50% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -43.60% vs -43.97% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -21.56% vs -34.60% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 57.14% vs 3.19% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Aarti Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
418.33
369.97
48.36
13.07%
Other Operating Income
0.00
0.00
0.00
Total Operating income
418.33
369.97
48.36
13.07%
Raw Material Cost
203.46
127.64
75.82
59.40%
Purchase of Finished goods
23.26
7.36
15.90
216.03%
(Increase) / Decrease In Stocks
-16.95
-29.50
12.55
42.54%
Employee Cost
43.41
83.05
-39.64
-47.73%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
90.43
73.14
17.29
23.64%
Total Expenditure (Excl Depreciation)
343.62
261.69
81.93
31.31%
Operating Profit (PBDIT) excl Other Income
74.71
108.28
-33.57
-31.00%
Other Income
0.05
1.75
-1.70
-97.14%
Operating Profit (PBDIT)
74.76
110.03
-35.27
-32.05%
Interest
10.67
15.67
-5.00
-31.91%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
64.09
94.36
-30.27
-32.08%
Depreciation
24.77
29.82
-5.05
-16.93%
Profit Before Tax
38.69
64.43
-25.74
-39.95%
Tax
10.77
20.36
-9.59
-47.10%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
28.56
44.18
-15.62
-35.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
28.56
44.18
-15.62
-35.36%
Share in Profit of Associates
-0.64
-0.11
-0.53
-481.82%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.92
44.07
-16.15
-36.65%
Equity Capital
45.32
9.78
35.54
363.39%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
3.08
2.25
0.83
36.89%
Diluted Earnings per share
3.08
2.75
0.33
12.00%
Operating Profit Margin (Excl OI)
17.86%
29.27%
0.00
-11.41%
Gross Profit Margin
15.32%
25.50%
0.00
-10.18%
PAT Margin
6.67%
11.91%
0.00
-5.24%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 418.33 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 8.32% vs -31.50% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -8.67% vs 4.15% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 27.92 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -43.60% vs -43.97% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -48.88% vs 5.44% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 74.71 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -21.56% vs -34.60% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -20.24% vs 6.46% in Sep 2024

Quarterly - Interest
Interest 10.67 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 57.14% vs 3.19% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 93.65% vs 41.65% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.86%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024